Rheumatology Advance Access originally published online on August 18, 2006
Rheumatology 2007 46(3):409-411; doi:10.1093/rheumatology/kel300
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MHC2TA promoter polymorphism (168*G/A, rs3087456) is not associated with susceptibility to rheumatoid arthritis in British Caucasian rheumatoid arthritis patients
University of Oxford Institute of Musculoskeletal Sciences, Botnar Research Centre and 1Nuffield Department of Orthopaedic Surgery Nuffield Orthopaedic Centre, Oxford, UK.
Correspondence to: Pille Harrison, Botnar Research Centre, University of Oxford, Nuffield Orthopaedic Centre, Oxford OX3 7LD, UK. E-mail: pille.harrison{at}ndos.ox.ac.uk
| Abstract |
|---|
Objective. To investigate the association of a single-nucleotide polymorphism (SNP) in the promoter region of MHC2TA gene (168*G/A, rs3087456), which has previously been described in a Swedish rheumatoid arthritis (RA) cohort, in British Caucasian RA patients.
Methods. We genotyped 733 RA patients and 613 healthy controls for MHC2TA 168*G/A SNP by amplification-refractory mutation system (ARMS). Data were analysed using SPSS version 13.0 software and the chi-square test was applied where appropriate.
Results. The MHC2TA 168*G/A SNP was not associated with increased susceptibility to RA in our patients. Stratifying the patients according to the presence or absence of rheumatoid factor (RF) showed the SNP to be more common in RF negative patients, but this did not reach statistical significance.
Conclusion. We did not confirm the previously reported association of this MHC2TA polymorphism with RA in our UK population despite its ethnic similarities with the Swedish population in which it was first described.
KEY WORDS: MHC2TA, Rheumatoid arthritis, HLA, Rheumatoid factor negative
Submitted 11 June 2006;
revised version accepted 14 July 2006.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
P G Bronson, L A Criswell, and L F Barcellos The MHC2TA -168A/G polymorphism and risk for rheumatoid arthritis: a meta-analysis of 6861 patients and 9270 controls reveals no evidence for association Ann Rheum Dis, July 1, 2008; 67(7): 933 - 936. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Harnesk, M. Swanberg, J. Ockinger, M. Diez, O. Lidman, E. Wallstrom, A. Lobell, T. Olsson, and F. Piehl Vra4 Congenic Rats with Allelic Differences in the Class II Transactivator Gene Display Altered Susceptibility to Experimental Autoimmune Encephalomyelitis J. Immunol., March 1, 2008; 180(5): 3289 - 3296. [Abstract] [Full Text] [PDF] |
||||

